Stock listing

A1W50M Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: A1W50M · LSX · EUR · DE

A1W50M:LSX is the listing for Fate Therapeutics, Inc., a public biotechnology company based in the United States. The company specializes in developing innovative cell therapies aimed at treating cancer and immune disorders. With a market capitalization of around $324 million, Fate Therapeutics is committed to enhancing its proprietary technology platform to deliver better patient outcomes. Recent developments and filings may provide insights into the company's progress and future initiatives.

A1W50M:LSXEURDEUpdated July 24, 2026
Fate Therapeutics, Inc. logo
Ticker
A1W50M:LSX
Asset type
Stock
Market cap
$280.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Fate Therapeutics, Inc. A1W50M:LSX stock context

A1W50M:LSX is the listing for Fate Therapeutics, Inc., a public biotechnology company based in the United States. The company specializes in developing innovative cell therapies aimed at treating cancer and immune disorders. With a market capitalization of around $324 million, Fate Therapeutics is committed to enhancing its proprietary technology platform to deliver better patient outcomes. Recent developments and filings may provide insights into the company's progress and future initiatives.

Research Fate Therapeutics, Inc.

Alternate listings